Skip to main content
. 2020 Oct 19;8(10):433. doi: 10.3390/biomedicines8100433
AGEs advanced glycation end products
DME diabetic macular edema
DR diabetic retinopathy
FGF21 Fibroblast growth factor 21
NAFLD nonalcoholic fatty liver disease
NASH nonalcoholic steatohepatitis
PPARα peroxisome proliferator-activator receptor alpha
PKC protein kinase C
PEA palmitoylethanolamide
SPPARMα selective peroxisome proliferator-activated receptor alpha modulator
VEGF vascular endothelial growth factor
VAP-1 vascular adhesion protein-1